Futura Medical
AGM statement confirms MED3000 filings on trackFutura Medical
Nearing the critical point in Erectile DysfunctionFutura Medical
MED3000: more detail on FM57 resultsFutura Medical
Encouraging FY19 results and MED3000 updateFutura Medical
MED3000 European regulatory pathway is clearerFutura Medical
Fund raise of £3.25m, at 8p a share, confirmed at EGMFutura Medical
Remarkable data from pivotal trial opens new possibilitiesFutura Medical
Are these unprecedented results a major opportunity?Futura Medical
Elegant and effective treatment for Erectile Dysfunction